ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)

13 5月 2025 16:01:00 条件 Nasdaq GlobeNewswire

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

12 5月 2025 16:45:30 条件 Nasdaq GlobeNewswire

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025

05 5月 2025 08:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

02 5月 2025 09:45:50 条件 NetDania Notify

Ascendis Pharma Reports First Quarter 2025 Financial Results

01 5月 2025 16:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

01 5月 2025 09:45:35 条件 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

30 4月 2025 13:59:46 条件 NetDania Notify

Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

24 4月 2025 16:01:00 条件 Nasdaq GlobeNewswire

Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia

31 3月 2025 16:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

17 3月 2025 09:45:02 条件 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

03 3月 2025 09:45:07 条件 NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

28 2月 2025 12:27:23 条件 NetDania Notify

Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference

24 2月 2025 16:01:00 条件 Nasdaq GlobeNewswire

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs

12 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results

12 2月 2025 16:01:00 条件 Nasdaq GlobeNewswire

Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025

05 2月 2025 16:01:00 条件 Nasdaq GlobeNewswire

Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference

12 1月 2025 17:00:00 条件 Nasdaq GlobeNewswire

Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 1月 2025 08:30:00 条件 Nasdaq GlobeNewswire

YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults

19 12月 2024 08:30:00 条件 Nasdaq GlobeNewswire

New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26

16 12月 2024 08:30:00 条件 Nasdaq GlobeNewswire